Dyne Therapeutics, Inc.Dyne Therapeutics, Inc.Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc.

No trades
See on Supercharts

Price target

51.400.000.00%
The 10 analysts offering 1 year price forecasts for DYN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to DYN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


DYN EPS for the last quarter is −0.96 USD despite the estimation of −0.71 USD. In the next quarter EPS is expected to reach −0.93 USD. Track more of Dyne Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Dyne Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Dyne Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, DYN price target is 51.40 USD with a max estimate of 66.00 USD and a min estimate of 34.00 USD. Check if this forecast comes true in a year, meanwhile watch Dyne Therapeutics, Inc. stock price chart and keep track of the current situation with DYN news and stock market news.
We've gathered opinions of 10 analysts rating DYN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.